Screener
Denali Therapeutics Inc. DNLI Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s price / book?
- Denali Therapeutics Inc. (DNLI) reported price / book of 4.9× in Q2 2026.
- How has Denali Therapeutics Inc.'s price / book changed year-over-year?
- Denali Therapeutics Inc.'s price / book increased by 140.0% year-over-year, from 2× to 4.9×.
- What is the long-term trend for Denali Therapeutics Inc.'s price / book?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s price / book has grown at a -22.1% compound annual growth rate (CAGR), from 8.9× to 2.5×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Denali Therapeutics Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude